I sold Bayer $BAYN (+0,25%) . Overall, the stock has risen sharply in recent months due to the positive outlook related to the legal disputes in the U.S., and I’m not sure if this trend can continue in the current, rather volatile market environment. I’m actually concerned that even the slightest bit of negative news could send the price tumbling quite a bit.
Bayer was my problem position, since I’d bought the stock years ago—even before the Monsanto acquisition. At one point, I was down 70%. I made sporadic additional purchases, which helped a little. Today, I’m selling at a loss of about 12%. It would have been nice to get back to my original purchase price, but ultimately, it’s probably just my own ego that’s breathing down my neck.
The sale makes sense given the focus of my portfolio (a dividend-paying portfolio), since Bayer pays no dividend—or only a symbolic one. In addition, I had $BAYN (+0,25%) , $AMGN (-1,06%) and $PFE (-0,8%) a certain overweight position in the pharmaceutical sector, which I’m now correcting.
I wish those who remain invested in Bayer the best of luck!
